Brief: Brain Q1 Adjusted EBITDA Loss Narrows To EUR 0.3 Mln

BRAIN Biotech AG

23/02/2022 06:40

Feb 23 (Reuters) - BRAIN BIOTECH AG  BNNn.DE :
    * VERY DYNAMIC START INTO FISCAL YEAR 2021/22, 3M REPORTING
    * SEES SALES FOR FISCAL YEAR IN RANGE OF EUR 43 - 45 MILLION
AND
AN ADJUSTED EBITDA AROUND BREAK-EVEN
    * WITH 6M RELEASE ON MAY 30TH, 2022, BRAIN WILL UPDATE ITS
GROUP
GUIDANCE FOR BREATEC ACQUISITION
    * CRISPR INVESTMENTS ARE EXPECTED TO BE AROUND EUR 2.5 - 3.5
MILLION
    * Q1 REVENUE OF BRAIN GROUP GREW TO EUR 10.2 MILLION
    * Q1 ADJUSTED EBITDA SIGNIFICANTLY IMPROVED FROM EUR -1.4
MILLION
TO EUR -0.3 MILLION

Source text for Eikon:  ID:nEQ4QX13ma 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))